In biology, there is a concept called apoptosis. It is the programmed death of a cell. The cell receives a signal, and it quietly dismantles itself from within. No drama. No inflammation. Just an orderly exit so the organism can keep functioning. It is one of the most elegant processes in nature, and it happens […]
From Cannibals to Zombies: Shorting Companies That Shouldn’t Exist Read More »
There’s a particular breed of investor who checks their brokerage account the way some people check their pulse. They want to see that dividend hit. They want confirmation that their money is working, that capital deployed is capital rewarded. And nowhere is this impulse stronger than among those who invest in business development companies. BDCs
Is Your Dividend a Return of Capital or a Return on Capital? Read More »
Everyone knows the secret to investment success. Buy low, sell high. It’s so simple that a child could understand it. Yet somehow, this basic principle has bankrupted more investors than any complex financial instrument ever could. The irony is almost perfect. The one thing everyone agrees on is the one thing almost nobody can do.
The Cult of the “Dip”: Why Buying Low is Psychologically Impossible for Most Read More »
There’s something almost rebellious about the 130/30 strategy. While the rest of the investment world spends centuries perfecting the art of picking winners, someone decided the real edge might come from simultaneously betting against losers. It’s a bit like a restaurant critic who doesn’t just recommend great restaurants but actively warns you away from bad
130/30 vs. Traditional Long-Only: Which Wins in a Bear Market? Read More »